Health and Wellness
STAT+: AMA wades into turbulent debate over AI regulation with new digital health center
In a recent Q&A, CEO John Whyte describes the Trump administration's examination of industry initiatives as 'understandable' Adobe Mario Aguilar reports on healthcare technology, including artificial intelligence, virtual reality, wearables,…
Your Trusted Source for Accurate and Timely Updates!
Lasted Health and Wellness
Women’s health has federal offices. Should men have one, too?
The early 1990s marked a pivotal moment in female health advocacy, with the establishment of various offices and initiatives to…
Leucovorin, Jeffrey Epstein, sex differences: Morning Rounds
Health and medicine are crucial aspects of our daily lives, and staying informed about the latest developments in the field…
FDA approves leucovorin for rare disorder, not for autism
The Food and Drug Administration recently approved a drug to treat a rare brain disorder that resembles autism. The medication,…
Dana-Farber and Brigham breakup latest: tensions and resolution
The recent breakup between Dana-Farber Cancer Institute and Mass General Brigham has taken a surprisingly amicable turn, with the institutions…
HHS autism, Himsification, kidney transplant: Morning Rounds
The cancellation of a federal advisory committee on autism, the Interagency Autism Coordinating Committee, has caused quite a stir in…
Dropping race from test helps Black Americans get kidney transplants
In the past, nephrologists made a groundbreaking effort to eliminate race from a crucial clinical algorithm in an attempt to…
FDA Vinay Prasad, Ozempic, autism diagnosis: Morning Rounds
Fresh turmoil at the FDA with Prasad’s exit Vinay Prasad, who served as the head of the Center for Biological…
FDA advisory committee meetings fade as controversial decisions grow
The Trump administration recently organized a private press conference to address concerns about an experimental treatment for Huntington's disease developed…